Rani Chovatiya, MD
Pain Medicine · Chicago, ILNPI 1730323403
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.2%), travel and lodging and entertainment — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Abbott at 43.0% of the total.
Across 97 payments — averaging $110.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$5K
- Boston Scientific$4K
- Medtronic$486
- Stratus Medical, LLC$472
- Spinefrontier, Inc.$463
- Novartis$264
- plus $878 from 6 others
What the payments were for
- Travel & lodging$4,57643%
- Food & beverage$6,14457%
- Entertainment$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 47 | $4,615 |
| Boston Scientific | 26 | $3,558 |
| Medtronic | 4 | $486 |
| Stratus Medical, LLC | 5 | $472 |
| Spinefrontier, Inc. | 2 | $463 |
| Novartis | 3 | $264 |
| Pacira Pharmaceuticals Incorporated | 2 | $241 |
| Arcutis Biotherapeutics, Inc. | 2 | $223 |
| Saluda Medical Americas, Inc. | 1 | $194 |
| Tersera Therapeutics LLC | 2 | $136 |
| Zavation Medical Products, LLC | 2 | $69 |
| Foundation Fusion Solutions, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Superion Indirect Decompression System$2,443
- PROCLAIM$2,289
- ETERNA$1,017
- InSpan$463
- Nimbus$406
- INTELLIS ADAPTIVESTIM$366
- Intracept$350
- EXPAREL$241
- ZORYVE$223
- Evoke$194
- Proclaim Family of SCS IPGs$154
- Proclaim IPG$142
- COSENTYX$120
- SPECTRA WAVEWRITER$118
How this compares
$10,736 in reported general payments places this provider in the 80th percentile of 233 pain medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 23 | $1,673 |
| Pregabalin | 28 | $888 |
| Tizanidine Hcl | 14 | $149 |
| Gabapentin | 11 | $111 |
| Tramadol Hcl | 12 | $81 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Chicago
- Steven CohenChicago$217K
- Tian YuChicago$32K
- Tetyana MarshallChicago$12K
- William LandphairChicago$12K
- Boss PoviengChicago$10K
- Robert HardenChicago$8K
- Michael WarrenChicago$7K
- Ricardo VallejoBloomington$2.3M
- David DickersonEvanston$558K
- Thomas DahlbergRockford$218K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.